Health
ARPA-H Backs Custom RNA Therapy Biotechs
By Editor • September 2, 2026 • 1 min read
ARPA-H is funding biotechs developing personalized RNA therapies, while UniQure seeks approval for its Huntington's disease treatment.
Read more
By Editor • September 2, 2026 • 1 min read
ARPA-H is funding biotechs developing personalized RNA therapies, while UniQure seeks approval for its Huntington's disease treatment.
Read more